The authors concluded that IFN-alpha therapy could result in the provocation of autoimmunity and they supported their hypothesis by citing several reports of other autoimmune disorders which occurred after IFN therapy in HCV-infected patients (including Grave’s disease and sarcoidosis). Here, IFNA1 is linked to sarcoidosis.